Capacity Bio
PrivateLast Round
Series A
Mar 31, 2023
Total Funding Raised
$35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Capacity Bio operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Series A round in March 2023.
Capacity Bio is a biotechnology company developing a first-in-class mitophagy therapeutic platform and advanced analytical tools to restore mitochondrial quality control for the treatment of neurodegenerative, autoimmune, and muscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capacity Bio Comparables
Compare Capacity Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vandria | 85% | |
| MitoRx Therapeutics | 81% | |
| Mitochon Pharmaceuticals | 79% |
For institutional investors. Book with your work email.
Capacity Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Capacity Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed, Series A |
| Remiges Ventures | Series A, Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 61% MoM.
- Mar 31, 2023
$35M round led by Insight Partners and RA Capital Management.
For institutional investors. Book with your work email.
Capacity Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Capacity Bio's valuation, stock price, and market status.
Is Capacity Bio a public or private company?
Capacity Bio is a private company.
What is the current stock price of Capacity Bio?
Capacity Bio is a private company, so its shares have no public market price. Caplight tracks Capacity Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Capacity Bio worth (valuation)?
Valuation information for Capacity Bio is not publicly available.
Can I buy Capacity Bio stock?
Capacity Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Capacity Bio's last funding round?
Capacity Bio's most recent funding round was Series A on March 31, 2023.
Who are the main investors in Capacity Bio?
Key investors in Capacity Bio include RA Capital Management, Insight Partners.
Will Capacity Bio IPO soon?
No public IPO plans have been announced for Capacity Bio.
How can I track Capacity Bio secondary market activity?
Caplight tracks bids, offers, and trades in Capacity Bio's shares on secondary markets.